Registro:

Referencias:

• Ohtsubo, K., Marth, J.D., Glycosylation in cellular mechanisms of health and disease (2006) Cell, 126, pp. 855-867
• Bard, F., Cracking the glycome encoder: signaling, trafficking, and glycosylation (2016) Trends Cell Biol., 26, pp. 379-388
• Moremen, K.W., Vertebrate protein glycosylation: diversity, synthesis and function (2012) Nat. Rev. Mol. Cell Biol., 13, pp. 448-462
• Pinho, S.S., Reis, C.A., Glycosylation in cancer: mechanisms and clinical implications (2015) Nat. Rev. Cancer, 15, pp. 540-555
• Albrecht, S., Glycosylation as a marker for inflammatory arthritis (2014) Cancer Biomark., 14, pp. 17-28
• Johnson, J.L., The regulatory power of glycans and their binding partners in immunity (2013) Trends Immunol., 34, pp. 290-298
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36, pp. 322-335
• Rabinovich, G.A., Toscano, M.A., Turning ‘sweet’ on immunity: galectin-glycan interactions in immune tolerance and inflammation (2009) Nat. Rev. Immunol., 9, pp. 338-352
• Nabi, I.R., The galectin lattice at a glance (2015) J. Cell Sci., 128, pp. 2213-2219
• Demetriou, M., Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation (2001) Nature, 409, pp. 733-739
• Bonzi, J., Pre-B cell receptor binding to galectin-1 modifies galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactions (2015) Nat. Commun., 6, p. 6194
• Partridge, E.A., Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis (2004) Science, 306, pp. 120-124
• Starossom, S.C., Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration (2012) Immunity, 37, pp. 249-263
• Kouo, T., Galectin-3 shapes antitumor immune responses by suppressing CD8+ T cells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells (2015) Cancer Immunol. Res., 3, pp. 412-423
• Lau, K.S., Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation (2007) Cell, 129, pp. 123-134
• Zhu, C., The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity (2005) Nat. Immunol., 6, pp. 1245-1252
• Rangachari, M., Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion (2012) Nat. Med., 18, pp. 1394-1400
• Croci, D.O., Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors (2014) Cell, 156, pp. 744-758
• Markowska, A.I., Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells (2011) J. Biol. Chem., 286, pp. 29913-29921
• Chen, W.S., Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR–3 (2016) Nat. Commun., 7, p. 11302
• Motz, G.T., Coukos, G., The parallel lives of angiogenesis and immunosuppression: cancer and other tales (2011) Nat. Rev. Immunol., 11, pp. 702-711
• Rabinovich, G.A., Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization (1998) J. Immunol., 160, pp. 4831-4840
• Sato, S., Hughes, R.C., Control of Mac-2 surface expression on murine macrophage cell lines (1994) Eur. J. Immunol., 24, pp. 216-221
• Barrionuevo, P., A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway (2007) J. Immunol., 178, pp. 436-445
• Correa, S.G., Opposite effects of galectin-1 on alternative metabolic pathways of L-arginine in resident, inflammatory, and activated macrophages (2003) Glycobiology, 13, pp. 119-128
• Zuniga, E., Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: modulation of microbicidal activity and survival (2001) Infect. Immun., 69, pp. 6804-6812
• Rostoker, R., Galectin-1 induces 12/15-lipoxygenase expression in murine macrophages and favors their conversion toward a pro-resolving phenotype (2013) Prostaglandin other Lipid Mediat., 107, pp. 85-94
• Malik, R.K., Galectin-1 stimulates monocyte chemotaxis via the p44/42 MAP kinase pathway and a pertussis toxin-sensitive pathway (2009) Glycobiology, 19, pp. 1402-1407
• Sano, H., Human galectin-3 is a novel chemoattractant for monocytes and macrophages (2000) J. Immunol., 165, pp. 2156-2164
• Sano, H., Critical role of galectin-3 in phagocytosis by macrophages (2003) J. Clin. Invest., 112, pp. 389-397
• Yamaoka, A., A human lectin, galectin-3 (epsilon bp/Mac-2), stimulates superoxide production by neutrophils (1995) J. Immunol., 154, pp. 3479-3487
• Hsu, D.K., Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses (2000) Am. J. Pathol., 156, pp. 1073-1083
• Jeon, S.B., Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway (2010) J. Immunol., 185, pp. 7037-7046
• Lalancette-Hebert, M., Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury (2012) J. Neurosci., 32, pp. 10383-10395
• Burguillos, M.A., Microglia-secreted galectin-3 acts as a Toll-like Receptor 4 ligand and contributes to microglial activation (2015) Cell Rep., 10, pp. 1626-1638
• Hoyos, H.C., Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination (2014) Neurobiol. Dis., 62, pp. 441-455
• MacKinnon, A.C., Regulation of alternative macrophage activation by galectin-3 (2008) J. Immunol., 180, pp. 2650-2658
• Jia, W., Galectin-3 accelerates M2 macrophage infiltration and angiogenesis in tumors (2013) Am. J. Pathol., 182, pp. 1821-1831
• Yildirim, C., Galectin-2 induces a proinflammatory, anti-arteriogenic phenotype in monocytes and macrophages (2015) PLoS ONE, 10, p. e0124347
• Jayaraman, P., Tim-3 binding to galectin-9 stimulates antimicrobial immunity (2010) J. Exp. Med., 207, pp. 2343-2354
• Sada-Ovalle, I., The Tim-3-galectin 9 pathway induces antibacterial activity in human macrophages infected with Mycobacterium tuberculosis (2012) J. Immunol., 12, pp. 5896-5902
• Anderson, A.C., Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells (2007) Science, 318, pp. 1141-1143
• Ma, C.J., Cis association of galectin-9 with Tim-3 differentially regulates IL-12/IL-23 expressions in monocytes via TLR signaling (2013) PLoS ONE, 8, p. e72488
• Vaitaitis, G.M., Wagner, D.H., Jr, Galectin-9 controls CD40 signaling through a Tim-3 independent mechanism and redirects the cytokine profile of pathogenic T cells in autoimmunity (2012) PLoS ONE, 7, p. e38708
• Leitner, J., TIM-3 does not act as a receptor for galectin-9 (2013) PLoS Pathog., 9, p. e1003253
• Wan, L., Galectin-12 enhances inflammation by promoting M1 polarization of macrophages and reduces insulin sensitivity in adipocytes (2016) Glycobiology, 7, pp. 732-744
• Bax, M., Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins (2007) J. Immunol., 179, pp. 8216-8224
• Ilarregui, J.M., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat. Immunol., 10, pp. 981-991
• Mari, E.R., Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis (2016) Eur. J. Immunol., 46, pp. 1783-1796
• Blois, S.M., A pivotal role for galectin-1 in fetomaternal tolerance (2007) Nat. Med., 13, pp. 1450-1457
• Poncini, C.V., Trypanosoma cruzi Infection Imparts a regulatory program in dendritic cells and T cells via galectin-1-dependent mechanisms (2015) J. Immunol., 195, pp. 3311-3324
• Mobergslien, A., Sioud, M., Galectin-1 and -3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-gamma production (2012) J. Leukoc. Biol., 91, pp. 461-467
• Fulcher, J.A., Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling (2009) J. Biol. Chem., 284, pp. 26860-26870
• Thiemann, S., Galectin-1 regulates tissue exit of specific dendritic cell populations (2015) J. Biol. Chem., 290, pp. 22662-22677
• Tesone, A.J., Satb1 overexpression drives tumor-promoting activities in cancer-associated dendritic cells (2016) Cell Rep., 14, pp. 1774-1786
• Kuo, P.L., Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor (2012) J. Biol. Chem., 287, pp. 9753-9764
• Fermin Lee, A., Galectin-3 modulates Th17 responses by regulating dendritic cell cytokines (2013) Am. J. Pathol., 183, pp. 1209-1222
• Fermino, M.L., Lack of galectin-3 increases Jagged1/Notch activation in bone marrow-derived dendritic cells and promotes dysregulation of T helper cell polarization (2016) Mol. Immunol., 76, pp. 22-34
• Breuilh, L., Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells (2007) Infect. Immun., 75, pp. 5148-5157
• Volarevic, V., Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury (2015) Eur. J. Immunol., 45, pp. 531-543
• Hsu, D.K., Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells (2009) J. Invest. Dermatol., 129, pp. 573-583
• Shan, M., Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals (2013) Science, 342, pp. 447-453
• Dai, S.Y., Galectin-9 induces maturation of human monocyte-derived dendritic cells (2005) J. Immunol., 175, pp. 2974-2981
• Hsu, Y.L., Up-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virus (2015) J. Cell. Mol. Med., 19, pp. 1065-1076
• Nagahara, K., Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions (2008) J. Immunol., 181, pp. 7660-7669
• Rabinovich, G.A., Evidence of a role for galectin-1 in acute inflammation (2000) Eur. J. Immunol., 30, pp. 1331-1339
• Woidacki, K., Mast cells rescue implantation defects caused by c-kit deficiency (2013) Cell Death Dis., 4, p. e462
• Chen, H.Y., Role of galectin-3 in mast cell functions: galectin-3-deficient mast cells exhibit impaired mediator release and defective JNK expression (2006) J. Immunol., 177, pp. 4991-4997
• Bambouskova, M., New regulatory roles of galectin-3 in high-affinity IgE receptor signaling (2016) Mol. Cell. Biol., 36, pp. 1366-1382
• Kojima, R., Galectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell line (2014) PLoS ONE, 9, p. e86106
• Ge, X.N., Regulation of eosinophilia and allergic airway inflammation by the glycan-binding protein galectin-1 (2016) Proc. Natl. Acad. Sci. U.S.A., 113, pp. 4837-4846
• Mello, C.B., Immunomodulatory effects of galectin-1 on an IgE-mediated allergic conjunctivitis model (2015) Invest. Ophthalmol. Vis. Sci., 56, pp. 693-704
• Rao, S.P., Galectin-3 functions as an adhesion molecule to support eosinophil rolling and adhesion under conditions of flow (2007) J. Immunol., 179, pp. 7800-7807
• Matsushita, N., Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction (2000) J. Biol. Chem., 275, pp. 8355-8360
• Chua, J.C., Galectin-10, a potential biomarker of eosinophilic airway inflammation (2012) PLoS ONE, 7, p. e42549
• Young, A.R., Functional characterization of an eosinophil-specific galectin, ovine galectin-14 (2009) Glycoconj. J., 26, pp. 423-432
• Cooper, D., Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow (2008) J. Leukoc. Biol., 83, pp. 1459-1466
• Auvynet, C., Galectin-1 promotes human neutrophil migration (2013) Glycobiology, 23, pp. 32-42
• Stowell, S.R., Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane (2009) Mol. Biol. Cell, 20, pp. 1408-1418
• Stowell, S.R., Human galectin-1,-2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells (2007) Blood, 109, pp. 219-227
• Nieminen, J., Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses (2005) J. Leukoc. Biol., 78, pp. 1127-1135
• Nieminen, J., Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer (2007) J. Biol. Chem., 282, pp. 1374-1383
• Bhaumik, P., Galectin-3 facilitates neutrophil recruitment as an innate immune response to a parasitic protozoa cutaneous infection (2013) J. Immunol., 190, pp. 630-640
• Mishra, B.B., Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia (2013) PLoS ONE, 8, p. e59616
• Fernandez, G.C., Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways (2005) Glycobiology, 15, pp. 519-527
• Nishi, N., Galectin-8 modulates neutrophil function via interaction with integrin alphaM (2003) Glycobiology, 13, pp. 755-763
• Vega-Carrascal, I., Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lung (2014) J. Immunol., 192, pp. 2418-2431
• Stowell, S.R., Innate immune lectins kill bacteria expressing blood group antigen (2010) Nat. Med., 16, pp. 295-301
• Croci, D.O., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma (2012) J. Exp. Med., 209, pp. 1985-2000
• Baker, G.J., Natural killer cells require monocytic Gr–1(+)/CD11b(+) myeloid cells to eradicate orthotopically engrafted glioma cells (2016) Oncoimmunology, 5, p. e1163461
• Wang, W., Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack (2014) J. Biol. Chem., 289, pp. 33311-33319
• Tsuboi, S., A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans (2011) EMBO J., 30, pp. 3173-3185
• Gleason, M.K., Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9 (2012) Blood, 119, pp. 3064-3072
• Golden-Mason, L., Galectin-9 functionally impairs natural killer cells in humans and mice (2013) J. Virol., 87, pp. 4835-4845
• Gauthier, L., Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering (2002) Proc. Natl. Acad. Sci. U.S.A., 99, pp. 13014-13019
• Espeli, M., Impaired B-cell development at the pre-BII-cell stage in galectin-1-deficient mice due to inefficient pre-BII/stromal cell interactions (2009) Blood, 113, pp. 5878-5886
• Elantak, L., Structural basis for galectin-1-dependent pre-B cell receptor (pre-BCR) activation (2012) J. Biol. Chem., 287, pp. 44703-44713
• Croci, D.O., Nurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1 (2013) Leukemia, 27, pp. 1413-1416
• Tsai, C.M., Phosphoproteomic analyses reveal that galectin-1 augments the dynamics of B-cell receptor signaling (2014) J. Proteomics, 103, pp. 241-253
• Clark, M.C., Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death (2012) Blood, 120, pp. 4635-4644
• Zuñiga, E., Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis (2001) J. Leukoc. Biol., 70, pp. 73-79
• Acosta-Rodriguez, E.V., Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection (2004) J. Immunol., 172, pp. 493-502
• Tabrizi, S.J., T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins (2009) J. Immunol., 182, pp. 1490-1499
• Anginot, A., Galectin 1 modulates plasma cell homeostasis and regulates the humoral immune response (2013) J. Immunol., 190, pp. 5526-5533
• Moritoki, M., Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3 (2013) PLoS ONE, 8, p. e60807
• Chen, I.J., Lateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and microfilaments coordinate basal and activation signaling (2007) J. Biol. Chem., 48, pp. 35361-35372
• Demotte, N., Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes (2008) Immunity, 28, pp. 414-424
• Antonopoulos, A., Loss of effector function of human cytolytic T lymphocytes is accompanied by major alterations in N- and O-glycosylation (2012) J. Biol. Chem., 287, pp. 11240-11251
• Petit, A.E., A major secretory defect of tumour-infiltrating T lymphocytes due to galectin impairing LFA-1-mediated synapse completion (2016) Nat. Commun., 7, p. 12242
• Mycko, M.P., Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination (2014) J. Neurosci., 34, pp. 8646-8658
• Bi, S., Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry (2011) Proc. Natl. Acad. Sci. U.S.A., 108, pp. 10650-10655
• Chen, H.Y., Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse (2009) Proc. Natl. Acad. Sci. U.S.A., 106, pp. 14496-14501
• Madireddi, S., Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies (2014) J. Exp. Med., 211, pp. 1433-1448
• de la Fuente, H., The leukocyte activation receptor CD69 controls T cell differentiation through its interaction with galectin-1 (2014) Mol. Cell. Biol., 34, pp. 2479-2487
• Lichtenstein, R.G., Rabinovich, G.A., Glycobiology of cell death: when glycans and lectins govern cell fate (2013) Cell Death Differ., 20, pp. 976-986
• Stillman, B.N., Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death (2006) J. Immunol., 176, pp. 778-789
• Matarrese, P., Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission (2005) J. Biol. Chem., 280, pp. 6969-6985
• Di Lella, S., When galectins recognize glycans: from biochemistry to physiology and back again (2011) Biochemistry, 50, pp. 7842-7857
• Toscano, M.A., Differential glycosylation of Th1, Th2 and Th-17 effector cells selectively regulates susceptibility to cell death (2007) Nat. Immunol., 8, pp. 825-834
• Rabinovich, G.A., Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis (1999) J. Exp. Med., 190, pp. 385-398
• Toscano, M.A., Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses (2006) J. Immunol., 176, pp. 6323-6332
• Banh, A., Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis (2011) Cancer Res., 71, pp. 4423-4431
• Juszczynski, P., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc. Natl. Acad. Sci. U.S.A., 104, pp. 13134-13139
• Dalotto-Moreno, T., Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease (2013) Cancer Res., 73, pp. 1107-1117
• Rubinstein, N., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251
• Cedeno-Laurent, F., Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma (2012) Blood, 119, pp. 3534-3538
• Cedeno-Laurent, F., Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity (2012) J. Invest. Dermatol., 132, pp. 410-420
• Fukumori, T., CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis (2003) Cancer Res., 63, pp. 8302-8311
• Yang, R.Y., Expression of galectin-3 modulates T-cell growth and apoptosis (1996) Proc. Natl. Acad. Sci. U.S.A., 13, pp. 6737-6742
• Deak, M., Novel role for galectin-1 in T-cells under physiological and pathological conditions (2015) Immunobiology, 220, pp. 483-489
• Norambuena, A., Galectin-8 induces apoptosis in Jurkat T cells by phosphatidic acid-mediated ERK1/2 activation supported by protein kinase A down-regulation (2009) J. Biol. Chem., 284, pp. 12670-12679
• Tribulatti, M.V., Galectin-8 induces apoptosis in the CD4(high)CD8(high) thymocyte subpopulation (2007) Glycobiology, 17, pp. 1404-1412
• Paclik, D., Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle (2008) PLoS ONE, 3, p. e2629
• Su, E.W., Galectin-9 regulates T helper cell function independently of Tim-3 (2011) Glycobiology, 21, pp. 1258-1265
• Oomizu, S., Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner (2012) Clin. Immunol., 143, pp. 51-58
• Li, Y., The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity (2011) Mol. Immunol., 48, pp. 670-677
• Jiang, H.R., Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis (2009) J. Immunol., 182, pp. 1167-1173
• Fermino, M.L., Galectin-3 negatively regulates the frequency and function of CD4(+) CD25(+) Foxp3(+) regulatory T cells and influences the course of Leishmania major infection (2013) Eur. J. Immunol., 43, pp. 1806-1817
• Sampson, J.F., Galectin-8 promotes regulatory T-cell differentiation by modulating IL-2 and TGFbeta signaling (2016) Immunol. Cell Biol., 94, p. 220
• Wu, C., Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells (2014) Immunity, 41, pp. 270-282
• Cedeno-Laurent, F., Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression (2012) J. Immunol., 188, pp. 3127-3137
• Garin, M.I., Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells (2007) Blood, 109, pp. 2058-2065
• Kubach, J., Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function (2007) Blood, 110, pp. 1550-1558
• Wang, J., Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis (2009) J. Immunol., 182, pp. 4036-4045
• Rutkowski, M.R., Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation (2015) Cancer Cell, 27, pp. 27-40
• Bergers, G., Hanahan, D., Modes of resistance to anti-angiogenic therapy (2008) Nat. Rev. Cancer, 8, pp. 592-603
• Thijssen, V.L., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res., 70, pp. 6216-6224
• Laderach, D.J., A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2013) Cancer Res., 73, pp. 86-96
• Markowska, A.I., Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response (2010) J. Exp. Med., 207, pp. 1981-1993
• Delgado, V.M., Modulation of endothelial cell migration and angiogenesis: a novel function for the ‘tandem-repeat’ lectin galectin-8 (2011) FASEB J., 25, pp. 242-254
• Mathieu, V., Galectin-1 in melanoma biology and related neo-angiogenesis processes (2012) J. Invest. Dermatol., 132, pp. 2245-2254
• Baston, J.I., Targeting galectin-1-induced angiogenesis mitigates the severity of endometriosis (2014) J. Pathol., 234, pp. 329-337
• Hsieh, S.H., Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene, 27, pp. 3746-3753
• D'Haene, N., VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis (2013) PLoS ONE, 8, p. e67029
• Nangia-Makker, P., Galectin-3 induces endothelial cell morphogenesis and angiogenesis (2000) Am. J. Pathol., 156, pp. 899-909
• Heusschen, R., Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis (2014) Biochim. Biophys. Acta, 1842, pp. 284-292
• Vasta, G.R., Roles of galectins in infection (2009) Nat. Rev. Microbiol., 7, pp. 424-438
• Mariño, K., A systematic approach to protein glycosylation analysis: a path through the maze (2010) Nat. Chem. Biol., 6, pp. 713-723
• Gabius, H.J., From lectin structure to functional glycomics: principles of the sugar code (2011) Trends Biochem. Sci., 36, pp. 298-313
• Yang, Z., Engineered CHO cells for production of diverse, homogeneous glycoproteins (2015) Nat. Biotechnol., 33, pp. 842-844
• Stanley, P., What have we learned from glycosyltransferase knockouts in mice? (2016) J. Mol. Biol., 428, pp. 3166-3182
• Thiemann, S., Baum, L.G., Galectins and immune responses-just how do they do those things they do? (2016) Annu. Rev. Immunol., 34, pp. 243-264
• Rabinovich, G., Regulated expression of a 16-kd galectin-like protein in activated rat macrophages (1996) J. Leukoc. Biol., 59, pp. 363-370
• Sato, S., Hughes, R.C., Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages (1994) J. Biol. Chem., 269, pp. 4424-4430
• Thijssen, V.L., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc. Natl. Acad. Sci. U.S.A., 103, pp. 15975-15980
• Etulain, J., Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors (2014) PLoS ONE, 9, p. e96402
• Thijssen, V.L., The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells (2008) Am. J. Pathol., 172, pp. 545-553

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------